Annexon, Inc. (ANNX)
NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 5.1000 |
| 開市 | 5.1900 |
| 買盤 | 4.7100 x 200 |
| 賣出價 | 4.7700 x 600 |
| 今日波幅 | 4.6700 - 5.2900 |
| 52 週波幅 | 1.5700 - 8.4000 |
| 成交量 | |
| 平均成交量 | 1,856,003 |
| 市值 | 432.922M |
| Beta 值 (5 年，每月) | 1.29 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1.7700 |
| 業績公佈日 | 2024年5月13日 - 2024年5月20日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 15.60 |
ZacksAnnexon (ANNX) to Report Q1 Earnings: What's in the Cards?
Annexon (ANNX) is expected to provide updates from the phase III study evaluating its lead candidate, ANX005, for the treatment of GBS in the first-quarter earnings release.
ZacksDown -43.02% in 4 Weeks, Here's Why You Should You Buy the Dip in Annexon (ANNX)
Annexon (ANNX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
ZacksAre Medical Stocks Lagging Annexon (ANNX) This Year?
Here is how Annexon, Inc. (ANNX) and Adma Biologics (ADMA) have performed compared to their sector so far this year.
